Chengcheng Ren

No ORCID on file · 5 papers in corpus · active 2023-2025

Study types

  • other 2
  • preprint 2
  • article 1

Condition tags

  • endometriosis 5
other 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1748838

[This corrects the article DOI: 10.3389/fimmu.2023.1115504.].

other 2025
International journal of women's health ·doi:10.2147/IJWH.S552629

BACKGROUND: Endometriosis (EMs) is a benign gynecological disorder that exhibits several malignant characteristics, including proliferation and angiogenesis. N6-methyladenosine (m6A) modification plays a crucial role in regulating RNA splic…

preprint 2024
·doi:10.21203/rs.3.rs-4509482/v1

Abstract Background: N6-methyladenosine(m6A) modification regulates the processes of RNA splicing, subcellular localization, translation and stability by changing the RNA structure and the interaction between RNA and RNA-binding proteins to…

preprint 2023
·doi:10.21203/rs.3.rs-3003927/v1

Abstract Background N6-methyladenosine(m6A) modification regulates the processes of RNA splicing, subcellular localization, translation and stability by changing the RNA structure and the interaction between RNA and RNA-binding proteins to …

article 2023
Frontiers in immunology ·doi:10.3389/fimmu.2023.1115504

BACKGROUND: Endometriosis (EM) is a benign, multifactorial, immune-mediated inflammatory disease that is characterized by persistent activation of the NF-κB signaling pathway and some features of malignancies, such as proliferation and lymp…